Discover 1 curated intelligence briefings related to this specific topic.
The financial burden of personalized medicine is not a pricing failure but a production inefficiency. By integrating CAD-like molecular design with predictive manufacturing, the industry is finally decoupling therapeutic complexity from astronomical cost.
